Tower Research Capital LLC (TRC) - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 40 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$41,231
-31.7%
17,696
-30.3%
0.00%
-50.0%
Q2 2023$60,395
+109709.1%
25,376
-14.6%
0.00%0.0%
Q1 2023$55
+52.8%
29,728
+55.4%
0.00%
+100.0%
Q4 2022$36
-99.7%
19,125
+193.9%
0.00%
Q3 2022$14,000
+40.0%
6,507
+88.4%
0.00%
Q2 2022$10,000
-23.1%
3,454
+16.1%
0.00%
Q1 2022$13,000
-43.5%
2,974
-32.4%
0.00%
Q4 2021$23,000
-42.5%
4,400
-27.2%
0.00%
-100.0%
Q3 2021$40,000
+135.3%
6,048
+133.9%
0.00%
Q2 2021$17,0000.0%2,586
-16.0%
0.00%
Q1 2021$17,000
+21.4%
3,080
+91.1%
0.00%
Q4 2020$14,000
-77.0%
1,612
-69.0%
0.00%
-100.0%
Q3 2020$61,000
+335.7%
5,203
+484.6%
0.00%0.0%
Q2 2020$14,000
+250.0%
890
+41.0%
0.00%
Q1 2020$4,000
-86.2%
631
-71.7%
0.00%
-100.0%
Q4 2019$29,000
-69.8%
2,227
-26.8%
0.00%
-66.7%
Q1 2019$96,000
+4700.0%
3,041
+4372.1%
0.01%
Q3 2018$2,000680.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders